Bioclinical features of haemophilia patients in Benin in 2023: Towards better care
Haemophilia · 2024
DOI: 10.1111/hae.15082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, 2024. Verfasst von Tatiana Baglo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Haematology laboratory, National Teaching Hospital Hubert Koutoukou Maga, Cotonou, Benin. Hauptthemen laut MEDLINE: Hemophilia A. Die Arbeit nennt 24 Literaturangaben. Gefördert von: French African Alliance for the Treatment of Haemophilia, World Federation of Haemophilia.
Abstract (Originalsprache)
Objective
To analyse the demographic, clinical and laboratory data of Beninese patients with haemophilia.
Method
A prospective survey was conducted in three different hospitals of Benin from April 2021 to March 2022, to analyse clinical and biological features of patients with haemophilia previously diagnosed or identified based on personal/family history.
Results
A total of 101 patients were studied, 97 with haemophilia A and 4 with haemophilia B, including 26 new cases identified after family investigation. Their median age was 11 years, and the most frequent initial manifestations were cutaneous‐mucosal haemorrhages (29.70%) and post‐circumcision haemorrhages (25.74%). Previous joint bleedings were present in 77% of them, with an arthropathy in 65 cases, which particularly affected the knees (75%), elbows (41%) and ankles (29%). Factor VIII (FVIII) levels combined with activated partial thromboplastin time (APTT) values did not always enable, as would be expected, the distinction between severe and moderate haemophilia, since they were >1 IU/dl in 31 of 74 patients with APTT > 80 s, and between 1 and 2 IU/dl in 26 other cases with previous joint haemorrhages, including 18 with chronic arthropathy. Therefore, for these patients, severe haemophilia could not be excluded, and this uncertainty probably reflects technical difficulties affecting the pre‐analytical and analytical stages of the APTT and FVIII/IX assays.
Conclusion
Our study proved that haemophilia is a significant reality in Benin, but also remains under‐diagnosed in some districts of the country. In addition, more reliable biological tests are needed in the future to better define the severity of the disease and improve treatment of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Haematology laboratory, National Teaching Hospital Hubert Koutoukou Maga, Cotonou, Benin.
- Faculty of Health Sciences, University of Abomey-Calavi, Abomey-Calavi, Benin.
- Faculty of Medicine, Mother and Child Department, University of Parakou, Parakou, Benin.
- Haematology laboratory, Aritide le Dantec Hospital, Dakar, Senegal.
- Pharmacy and Odontostomatology, Faculty of Medicine, Cheikh Anta Diop University of Dakar, Dakar, Senegal.
- Laboratory of Hematology, Bordeaux University Hospital, Pessac, France.
ORCID-Profile: Claire Pouplard
Förderung
- French African Alliance for the Treatment of Haemophilia
- World Federation of Haemophilia
Zitieren
APA
Baglo, T., Zohoun, A., Mohamed, F. A., Araba, F., Houssou, B., Anani, L., Kindé-Gazard, D., Fall, A. T., Ryman, A., Gruel, Y., & Pouplard, C. (2024). Bioclinical features of haemophilia patients in Benin in 2023: Towards better care. Haemophilia. https://doi.org/10.1111/hae.15082
Vancouver
Baglo T, Zohoun A, Mohamed FA, Araba F, Houssou B, Anani L, et al. Bioclinical features of haemophilia patients in Benin in 2023: Towards better care. Haemophilia. 2024. doi:10.1111/hae.15082
BibTeX
@article{Baglo2024,
author = {Baglo, Tatiana and Zohoun, Alban and Mohamed, Falilatou Agbeille and Araba, Ferrelle and Houssou, Bienvenu and Anani, Ludovic and Kindé-Gazard, Dorothée and Fall, Awa Touré and Ryman, Anne and Gruel, Yves and Pouplard, Claire},
title = {Bioclinical features of haemophilia patients in Benin in 2023: Towards better care},
journal = {Haemophilia},
year = {2024},
doi = {10.1111/hae.15082}
}
EUVIMED